Home / Recalls / Caraco Pharmaceutical Laboratories Ltd. / D-003-2013

D-003-2013 Class II Terminated

Recalled by Caraco Pharmaceutical Laboratories Ltd. — Cranbury, NJ

Recall Details

Product Type
Drugs
Report Date
October 10, 2012
Initiation Date
August 21, 2012
Termination Date
November 19, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 2424 Cartons b) 2675 Cartons

Product Description

Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.

Reason for Recall

Crystallization: Presence of crystals of Nimodipine within the capsule solution.

Distribution Pattern

One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts

Code Information

Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13

Other recalls by Caraco Pharmaceutical Laboratories Ltd.

  • D-1511-2014 Class II — Cephalexin Capsules, USP, 500 mg, packaged in a) 100-count bottles (NDC 62756-29 (June 26, 2014)
  • D-1510-2014 Class II — Cephalexin Capsules, USP, 250 mg, packaged in a) 100-count bottles (NDC 62756-29 (June 26, 2014)
  • D-1415-2014 Class II — Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in (June 12, 2014)
  • D-1407-2014 Class II — Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Ste (April 9, 2014)
  • D-1296-2014 Class III — Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30 count bottle, OTC Manufactur (April 9, 2014)
  • D-1297-2014 Class III — Children's Cetirizine Hydrochloride Chewable Tablets, 10 mg, 30 count bottle, O (April 9, 2014)
  • D-1283-2014 Class II — Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, packaged in a) 30-co (March 20, 2014)
  • D-1284-2014 Class II — Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, packaged in a) 30-c (March 20, 2014)
  • D-1081-2014 Class II — Oxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: Car (January 29, 2014)
  • D-1089-2014 Class II — Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx only, 500 count bottles (January 28, 2014)